Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Institutionalizing Externalization At Big Pharma – The Third Leg

Mar 26 2012

Related Content

With Pharma Ready to Pare Portfolios, Project Financing Funds Make Their Pitches

Jun 01 2010

Biogen Idec Buys Stromedix, Bringing IPF Candidate Full Circle

Feb 14 2012

GSK's Virtual-Proof-of-Concept Unit in Tune with Lilly's Chorus

Dec 01 2009

Merck's Capital Idea: Industry's Latest Push to Strengthen VC Ties

Sep 01 2011

Atlas, CMEA Test New Biotech Model

Apr 01 2011

Biopharma Out-licensing: 2012’s “In” Thing?

Jan 24 2012

Novartis Plans To Buy Back Speedel For $880 Million

Jul 10 2008

Lilly's Chorus Experiment

May 01 2007

Synosis: the Financial Leverage of Translational Medicine

Jan 01 2007

Movetis Takes GI from J&J

Feb 01 2007

Related Companies

Merck & Co., Inc.

Eli Lilly and Company

Eli Lilly and Company

Pfizer Inc.

GSK plc

Roche Holding AG

IQVIA Holdings Inc.

Solvay SA

Eisai Co., Ltd.

Novartis AG

Johnson & Johnson

Biogen, Inc.

Stromedix, Inc.

AstraZeneca PLC

Additional Topics

Strategy Business Strategies Deals BioPharmaceutical

More from Business Strategy

More from In Vivo

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window